Quest Diagnostics to Speak at the Morgan Stanley 20th Annual Global Healthcare Conference

SECAUCUS, N.J., Sept. 8, 2022 /PRNewswire/ — Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley 20th Annual Global Healthcare Conference. Jim Davis, CEO-elect, and Sam…